Rapamycin May Slow Aging in Human Skin, Study FindsNov-26-Sell-UPI
November 26, 2019
Christian Sell, PhD, an associate professor in the College of Medicine, was quoted in Nov. 26 United Press International and Specialty Medical Dialogues stories and a Medical Life Sciences story on Nov. 25 about his research exploring the use of Rapamycin, a drug typically used to prevent organ rejection in transplant patients, to reduce signs of skin aging.
Related:
Drexel News is produced by
University Marketing and Communications.